Key facts
- Elumn8 Medical’s last known valuation is $44.5M (Feb 2026).
- It has raised $17.5M; the latest was Later Stage VC ($17.5M) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Elumn8 Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Elumn8 Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elumn8 Medical
Operator of a medical technology company intended to develop advanced tools for treating complex heart conditions. The company offers an investigational medical device that combines real-time intra-vessel imaging using optical coherence tomography with guidewire crossing and re-entry capabilities in a single integrated catheter, enabling cardiologists to increase procedure success, reduce risks, and make treating complex blockages fast and safe.
- Sector
- Healthcare
- HQ
- Campbell, CA, United States
- Founded
- 2019
- Employees
- 14
- Website
- elumn8.com/
- Ownership
- Privately Held (backing)
Elumn8 Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elumn8 Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elumn8 Medical in its N-PORT filings yet. We sweep new filings monthly.